• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA SYNTHETIC CARTILAGE IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA SYNTHETIC CARTILAGE IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Catalog Number CAR-10
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthritis (1723); Cyst(s) (1800); Insufficient Information (4580)
Event Date 06/29/2022
Event Type  Injury  
Manufacturer Narrative
Analysis results are not available at the time of this report.A follow-up report will be sent when the analysis is complete.A review of the device history is not possible because the lot number was not communicated.Should additional information become available, it will be provided on a supplemental report.
 
Event Description
It was reported that, bilateral cartiva implants revised to mtp fusion.
 
Manufacturer Narrative
Correction b2, h6 clinical.The reported event could be confirmed, since the device was returned indicating a revision surgery was performed.The device inspection revealed the following: the device was returned in a container with a small amount of saline.Device exhibits translucent, whitish hue throughout the body.Visual examination of the implant found the articulating surface to be partially smooth and partially scratched and indented.These indentations also had some material ¿tags¿ around the edges, indicating they could have been caused by more recent damage, such as implant removal.Medical affairs was consulted on the details of this case.Per their review, "this case is about a patient with a longstanding, progressive osteoarthritis of the first mtp-joints (the rigidity coming with that explains the term hallux rigidus) and an interphalangeal hallux valgus on both sides.The latter being corrected with a closing wedge osteotomy of the distal phalanx in both feet, that was stabilized with a small staple.The hallux rigidus was surgically treated with a cartiva implant in the mtp i joints of both feet.The x-ray shows an end-stage osteoarthritis with deformation of the mtp i joint surfaces and a subchondral cyst on the right mtp i joint.Due to the progression of the disease the cartiva implant is not functional any longer.Without further clinical information, this may explain the choice for a fusion of the joint." although the device was returned, the root cause was unable to be determined with the available information.More detailed information about the complaint event as well as the affected device must be available in order to determine the root cause of the complaint event.A review of the device history was not possible because the lot number was not communicated.No corrective actions are required at this time.A review of the labeling did not indicate any abnormalities.No indications of material, manufacturing or design related problems were found during the investigation.If any additional information is provided, the investigation will be reassessed.
 
Event Description
It was reported that, bilateral cartiva implants revised to mtp fusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA SYNTHETIC CARTILAGE IMPLANT
Type of Device
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer (Section G)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer Contact
anna jusinski
325 corporate drive
mahwah, NJ 07430
2018315000
MDR Report Key15108530
MDR Text Key296653987
Report Number3009351194-2022-00106
Device Sequence Number1
Product Code PNW
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P150017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberCAR-10
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/12/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-